OTC Industry News Roundup: Earnings, User Fee Webinar, UK Ad Enforce
This article was originally published in The Pink Sheet
Sensodyne shines for Glaxo-Novartis JV; and international growth leads Prestige Brands OTCs.
You may also be interested in...
CDER officials and industry met in July to discuss "the ground rules governing the OTC monograph user fee." CHPA CEO Scott Melville cautions: "No one is going to rush into an agreement that we're going to have to live with for decades."
Compromise GMO legislation passes House; private equity looks for health, wellness investments, including China; and more news in brief.
The Swedish firm pays $40m for the PediaCare and Fiber Choice brands in addition to New Skin Liquid Bandages, which are available in spray and liquid delivery and are "the main profitability contributor in the acquired portfolio," says CEO Peter Wolpert.